Technical Data
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1)
Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics.

Suitable for use in ELISA. Other applications not tested.

Recommended Dilution:
ELISA: 1ug/ml
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
PabIgGAffinity Purified
Synthetic peptide corresponding to the hemagglutinin protein from seasonal Influenza A/Brisbane/59/2007 (H1N1). (Genbank Number: ACA28844)
Purified by immunoaffinity chromatography.
Supplied as a liquid in PBS, 0.02% sodium azide.
Recognizes the Hemagglutinin protein from the H1N1 strain of seasonal Influenza A. Recognizes a peptide sequence that is unique from the sequences recognized by I7650-04L and I7650-04M. Does not crossreact with the corresponding peptide from the swine-origin Influenza A/California/14/2009 (H1N1).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Thompson, W.W., et al., JAMA 289: 179-186 (2003). 2. Dawood, F.S., et al., N. Engl. J. Med. 360: 2605-2615 (2009). 3. Butler, D., Nature 458: 1082-1083 (2009). 4. Morens, D.M., et al., “The Persistent Legacy of the 1918 Influenza Virus,” N. Engl. J. Med., June 29 (2009). 5. Garten, R.J., et al., “Antigenic and Genetic Characteristics of Swine-Origin 2009 A (H1N1) Influenza Viruses Circulating in Humans,” Science, May 22 (2009).